Orasep by is a Otc medication manufactured, distributed, or labeled by Llorens Pharmaceutical International Division, Lex Inc.. Drug facts, warnings, and ingredients follow.
Warnings:
Allergy alert: Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or any other 'caine' anesthetics.
Sore throat warning: If sore throat is sever, persists for more than2 days, is accompanied or followed by fever, headache, rash, nausea, or vomitings, consult a doctor promptly.
Stop use and ask a doctor if sore mouth symptoms do not improve in 7 days, or if irritation, pain or redness persist or worsens.
Do not exceed recommended dosage.
When using this product do not get into eyes. If contact occurs, rinse eyes thoroughly with water. If irritation persists, consult a doctor.
ORASEP
benzocaine, menthol, cetylpyridinium chloride liquid |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
Labeler - Llorens Pharmaceutical International Division (037342305) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ORASEP 87837446 5586007 Live/Registered |
LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION, INC. 2018-03-16 |